Polish consensus: procedure in case of estrogen deficiency in women after breast cancer therapy.
Women surviving breast cancer in the postmenopausal period suffer from hormonal alternations with adverse effect on mental status and functioning of a number of organs and systems. Two thirds of these women had menopause before the diagnosis of breast cancer. In the remaining one-third ovarian failure is natural or induced by chemotherapy. Doctors cautiously approach the use of estrogen therapy in this group of patients. Their fears are not unsupported bearing in mind known epidemiological data exist linking breast cancer with the use of hormonal therapy. The purpose of this review is to evaluate current data on hormonal use and breast cancer risk.
Milewicz
A
A
Department of Endocrinology and Diabetology, Medical University, Pasteur str. 4, 50-367 Wroclaw, Poland.
Szymański
W
W
Ruzyłło
W
W
Zgliczyński
S
S
Reinfus
M
M
Zieliński
J
J
Debski
R
R
Demissie
M
M
Tworowska
U
U
D001943:Breast Neoplasms / Q000628:therapy*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000379:methods; D004967:Estrogens / Q000172:deficiency; D005260:Female; D006331:Heart Diseases / Q000517:prevention & control; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D011044:Poland; D017698:Postmenopause; D011372:Progestins / Q000008:administration & dosage
D004967:Estrogens; D011372:Progestins